Log in to your Inderes Free account to see all free content on this page.
AcouSort
15.55 SEK +6.14%Be the first to follow this company
AcouSort is active within medical technology. The company conducts research and development in a proprietary platform technology that utilises ultrasound to separate and analyse composition of biological cells. The technology is mainly used in the analysis of various cases of cancer as well as sepsis. Part of the research is done together with other stakeholders within field. The company was founded in 2010 and is based in Lund.
Revenue
-
EBIT %
-
P/E
-
Dividend yield-%
-
Target price
-
Recommendation
-
Updated
-
First North Stockholm
ACOU
Daily low / high price
14.7 / 16.5
SEK
Market cap
232.23M SEK
Turnover
416.33K SEK
Volume
27K
Financial calendar
Interim report
27.11.2024
Annual report
26.02.2025
Major OwnersSource: Millistream Market Data AB
Owner | Capital | Votes |
---|---|---|
Avanza Pension | 10.7 % | 10.7 % |
Thomas Laurell | 7.4 % | 7.4 % |
Premium
This content is for our Premium customers only.
ShowingAll content types
AcouSort AB - Interim Report for the period April - June 2024
The leading diagnostics company Werfen launches groundbreaking POC system with integrated acoustofluidic technology
Join Inderes community
Don't miss out - create an account and get all the possible benefits
FREE account
Stock market's most popular morning newsletter
Analyst comments and recommendations
Stock comparison tool
PREMIUM account
All company reports and content
Premium tools (e.g. insider transactions & stock screener)
Model portfolio